ACM
TPST icon

AIGH Capital Management’s Tempest Therapeutics TPST Stock Holding History

AIGH Capital Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,250
Closed -$125K – 52
2023
Q3 		$125K Hold
31,250
– – 0.06% 46
2023
Q2 		$516K Buy
+31,250
New +$786K 0.21% 45

Other funds holding TPST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

AIGH Capital Management's TPST Position: Q4 2023 in Review

AIGH Capital Management sold out of Tempest Therapeutics (TPST) in Q4 2023, closing a stake of 31,250 shares — an estimated $125K sold.

AIGH Capital Management first reported a position in TPST in Q2 2023 and held it in 2 quarters. The position peaked at $516K in Q2 2023. 31 funds tracked by Wall St. Rank hold TPST as of Q4 2023.

  • AIGH Capital Management reported no remaining Tempest Therapeutics position as of Q4 2023 after selling out during the quarter.
  • AIGH Capital Management sold 31,250 Tempest Therapeutics shares in Q4 2023, an estimated $125K.
  • AIGH Capital Management first reported a position in Tempest Therapeutics in Q2 2023 and held it in 2 quarters.
  • AIGH Capital Management's Tempest Therapeutics position peaked at $516K in Q2 2023.
  • 31 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2023.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.